TNF and breast cancer: Preclinical studies demonstrating important functional roles for the receptor activator of nuclear factor-κB (RANK) pathway, a member of the tumor necrosis factor (TNF) superfamily in breast development suggest that targeting this pathway could have utility in primary breast cancer prevention.